Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma

References

• Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–9. doi:10.3322/caac.21820.
   PubMed Web of Science ®Google Scholar
• Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, De Marzo AM, Nelson PS, Yegnasubramanian S. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18(2):79–92. doi:10.1038/s41585-020-00400-w.
   PubMed Web of Science ®Google Scholar
• Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014;371(5):424–33. doi:10.1056/NEJMoa1405095.
   PubMed Web of Science ®Google Scholar
• Sainio M, Visakorpi T, Tolonen T, Ilvesaro J, Bova GS. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer. Pathol Res Pract. 2018;214(6):848–56. doi:10.1016/j.prp.2018.04.015.
   PubMed Web of Science ®Google Scholar
• Moller A, Lobb RJ. The evolving translational potential of small extracellular vesicles in cancer. Nat Rev Cancer. 2020;20(12):697–709. doi:10.1038/s41568-020-00299-w.
   PubMed Web of Science ®Google Scholar
• Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17. doi:10.1038/s41556-018-0250-9.
   PubMed Web of Science ®Google Scholar
• Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. doi:10.1002/jev2.12404.
   PubMed Web of Science ®Google Scholar
• Jankovicova J, Secova P, Michalkova K, Antalikova JT. Tetraspanins, more than markers of extracellular vesicles in reproduction. Int J Mol Sci. 2020;21(20):7568. doi:10.3390/ijms21207568.
   PubMed Web of Science ®Google Scholar
• Santos MF, Rappa G, Fontana S, Karbanová J, Aalam F, Tai D, Li Z, Pucci M, Alessandro R, Morimoto C. et al. Anti-human CD9 fab fragment antibody blocks the extracellular vesicle-mediated increase in Malignancy of colon cancer cells. Cells. 2022;11(16):2474. doi:10.3390/cells11162474.
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977.
   PubMed Web of Science ®Google Scholar
• DeRita RM, Zerlanko B, Singh A, Lu H, Iozzo RV, Benovic JL, Languino LR. c-Src, insulin-like growth factor I receptor, G-Protein-coupled receptor kinases and focal adhesion kinase are enriched into prostate cancer cell exosomes. J Cell Biochem. 2017;118(1):66–73. doi:10.1002/jcb.25611.
   PubMed Web of Science ®Google Scholar
• Krishn SR, Salem I, Quaglia F, Naranjo NM, Agarwal E, Liu Q, Sarker S, Kopenhaver J, McCue PA, Weinreb PH. et al. The αvβ6 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis. J Extracell Vesicles. 2020;9(1):1763594. doi:10.1080/20013078.2020.1763594.
   PubMed Web of Science ®Google Scholar
• Osti D, Del Bene M, Rappa G, Santos M, Matafora V, Richichi C, Faletti S, Beznoussenko GV, Mironov A, Bachi A, et al. Clinical significance of extracellular vesicles in plasma from glioblastoma patients. Clin Cancer Res. 2019;25(1):266–76. doi:10.1158/1078-0432.CCR-18-1941.
   PubMed Web of Science ®Google Scholar
• Block T, Zezulinski D, Kaplan DE, Lu J, Zanine S, Zhan T, Doria C, Sayeed A. Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma. Front Oncol. 2022;12:963641. doi:10.3389/fonc.2022.963641.
   PubMed Web of Science ®Google Scholar
• Hofsli E, Wheeler TE, Langaas M, Laegreid A, Thommesen L. Identification of novel neuroendocrine-specific tumour genes. Br J Cancer. 2008;99(8):1330–39. doi:10.1038/sj.bjc.6604565.
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.19323.
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3(1):17009. doi:10.1038/nrdp.2017.9.
   PubMed Web of Science ®Google Scholar
• Haake SM, Rathmell WK. Renal cancer subtypes: should we be lumping or splitting for therapeutic decision making? Cancer. 2017;123(2):200–09. doi:10.1002/cncr.30314.
   PubMed Web of Science ®Google Scholar
• Mendhiratta N, Muraki P, Sisk AE Jr., Shuch B. Papillary renal cell carcinoma: review. Urol Oncol. 2021;39(6):327–37. doi:10.1016/j.urolonc.2021.04.013.
   PubMed Web of Science ®Google Scholar
• Alaghehbandan R, Przybycin CG, Verkarre V, Mehra R. Chromophobe renal cell carcinoma: novel molecular insights and clinicopathologic updates. Asian J Urol. 2022;9(1):1–11. doi:10.1016/j.ajur.2021.11.010.
   PubMed Web of Science ®Google Scholar
• Stridsberg M. The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours. Ups J Med Sci. 1995;100(3):169–99. doi:10.3109/03009739509178905.
   PubMedGoogle Scholar
• Louthan O. Chromogranin a in physiology and oncology. Folia Biol (Praha). 2011;57(5):173–81.
   PubMed Web of Science ®Google Scholar
• Soh MA, Garrett SH, Somji S, Dunlevy JR, Zhou XD, Sens MA, Bathula CS, Allen C, Sens DA. Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer. Cancer Cell Int. 2011;11(1):41. doi:10.1186/1475-2867-11-41.
   PubMedGoogle Scholar
• Korse CM, Taal BG, Vincent A, van Velthuysen MLF, Baas P, Buning-Kager JCGM, Linders TC, Bonfrer JMG. Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of chromogranin A, neuron specific enolase, progastrin-releasing peptide and cytokeratin fragments. Eur J Cancer. 2012;48(5):662–71. doi:10.1016/j.ejca.2011.08.012.
   PubMed Web of Science ®Google Scholar
• Astarloa R, Sanchez-Franco F, Cacicedo L, Garcia-Villanueva M. Differential expression of neurofilament triplet proteins in carcinoid tumours: an immunohistochemical study. Br J Cancer. 1991;63(5):715–18. doi:10.1038/bjc.1991.161.
   PubMed Web of Science ®Google Scholar
• Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, et al. N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Cancer Cell. 2016;29(4):536–47. doi:10.1016/j.ccell.2016.03.001.
   PubMed Web of Science ®Google Scholar
• Li Z, Xie J, Fei Y, Gao P, Xie Q, Gao W, Xu Z. GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN. Biochem Biophys Res Commun. 2019;510(3):339–44. doi:10.1016/j.bbrc.2018.12.169.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N, Ahn J, Akbani R, Ally A, Amin S, Andry C, Annala M, Aprikian A, Armenia J, Arora A, et al. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011–25. doi:10.1016/j.cell.2015.10.025.
   PubMed Web of Science ®Google Scholar
• Bowes AL, Tarabichi M, Pillay N, Van Loo P. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers. J Pathol. 2022;257(4):466–78. doi:10.1002/path.5914.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, et al. Extracellular Vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182(4):1044–61.e18. doi:10.1016/j.cell.2020.07.009.
   PubMed Web of Science ®Google Scholar
• Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, Kurtoglu S, Tripathi SK, Wang K, Hawkins A, et al. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes. Matrix Biol. 2019;77:41–57. doi:10.1016/j.matbio.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016;17(3):25. doi:10.1007/s11934-016-0576-4.
   PubMed Web of Science ®Google Scholar
• Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012;60(1):87–117. doi:10.1111/j.1365-2559.2011.04025.x.
   PubMed Web of Science ®Google Scholar
• Bery F, Cancel M, Chantôme A, Guibon R, Bruyère F, Rozet F, Mahéo K, Fromont G. The calcium-sensing receptor is a marker and potential driver of neuroendocrine differentiation in prostate cancer. Cancers (Basel). 2020;12(4):860. doi:10.3390/cancers12040860.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Beltran H. Clinical and biological features of neuroendocrine prostate cancer. Curr Oncol Rep. 2021;23(2):15. doi:10.1007/s11912-020-01003-9.
   PubMed Web of Science ®Google Scholar
• Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, Alnajar H, Eng KW, Conteduca V, Sboner A, et al. Immunogenomic landscape of neuroendocrine prostate cancer. Clin Cancer Res. 2023;29(15):2933–43. doi:10.1158/1078-0432.CCR-22-3743.
   PubMed Web of Science ®Google Scholar
• Saraswat M, Joenväära S, Musante L, Peltoniemi H, Holthofer H, Renkonen R. N-linked (N-) glycoproteomics of urinary exosomes [Corrected]. Mol Cell Proteomics: mCP. 2015;14(2):263–76. doi:10.1074/mcp.M114.040345.
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, Jicha GA, Karydas AM, Boxer A, Miller BL, et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease. FASEB J. 2016;30(12):4141–48. doi:10.1096/fj.201600816R.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Y, Gao X, Yuan Y, Zhao J, Zhou S, Wang H, Wang L, Xu G, Li X, et al. Plasma-derived exosomal ALIX as a novel biomarker for diagnosis and classification of pancreatic cancer. Front Oncol. 2021;11:628346. doi:10.3389/fonc.2021.628346.
   PubMed Web of Science ®Google Scholar
• Pietrowska M, Zebrowska A, Gawin M, Marczak L, Sharma P, Mondal S, Mika J, Polańska J, Ferrone S, Kirkwood JM, et al. Proteomic profile of melanoma cell-derived small extracellular vesicles in patients’ plasma: a potential correlate of melanoma progression. J Extracell Vesicles. 2021;10(4):e12063. doi:10.1002/jev2.12063.
   PubMed Web of Science ®Google Scholar
• Kim O, Hwangbo C, Tran PT, Lee JH. Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRnas secretion in lung cancer cells. Cell Death Dis. 2022;13(2):122. doi:10.1038/s41419-022-04594-2.
   PubMed Web of Science ®Google Scholar
• Folkmanis K, Junk E, Merdane E, Folkmane I, Folkmanis V, Ivanovs I, Eglitis J, Jakubovskis M, Laabs S, Isajevs S, et al. Clinicopathological significance of exosomal proteins CD9 and CD63 and DNA mismatch repair proteins in prostate adenocarcinoma and benign hyperplasia. Diagnostics (Basel). 2022;12(2):287. doi:10.3390/diagnostics12020287.
   PubMedGoogle Scholar
• Franceschini GM, Quaini O, Mizuno K, Orlando F, Ciani Y, Ku S-Y, Sigouros M, Rothmann E, Alonso A, Benelli M, et al. Noninvasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation. Cancer Discov. 2024;14:424–45. doi:10.1158/2159-8290.CD-23-0754.
   PubMed Web of Science ®Google Scholar
• Mugoni V, Ciani Y, Quaini O, Tomasini S, Notarangelo M, Vannuccini F, Marinelli A, Leonardi E, Pontalti S, Martinelli A. et al. Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients. J Extracell Biol. 2023;2(9):e108. doi:10.1002/jex2.108.
   PubMedGoogle Scholar
• Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71. doi:10.1093/nar/gkv1507.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. doi:10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57(1):289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
   Google Scholar
• Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BVSK, Varambally S, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22(3):298–305. doi:10.1038/nm.4045.
   PubMed Web of Science ®Google Scholar
• Salem I, Naranjo NM, Singh A, DeRita R, Krishn SR, Sirman LS, Quaglia F, Duffy A, Bowler N, Sayeed A, et al. Methods for extracellular vesicle isolation from cancer cells. Cancer Drug Resist. 2020;3:1–14. doi:10.20517/cdr.2019.118.
   PubMedGoogle Scholar
• Testa A, Quaglia F, Naranjo NM, Verrillo CE, Shields CD, Lin S, Pickles MW, Hamza DF, Von Schalscha T, Cheresh DA, et al. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer. Matrix Biol. 2023;124:49–62. doi:10.1016/j.matbio.2023.11.003.
   PubMed Web of Science ®Google Scholar
• Naranjo NM, Salem I, Harris MA, Languino LR. IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) modulates STAT1 expression in small extracellular vesicles. Biochem J. 2021;478(21):3905–21. doi:10.1042/BCJ20210580.
   PubMed Web of Science ®Google Scholar
• Quaglia F, Krishn SR, Sossey-Alaoui K, Rana PS, Pluskota E, Park PH, Shields CD, Lin S, McCue P, Kossenkov AV, et al. The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer. Sci Rep. 2022;12(1):18879. doi:10.1038/s41598-022-21711-5.
   PubMed Web of Science ®Google Scholar